Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07553585 · ClinicalTrials.gov registry record · NA
Survey to Test the Nicotine Concentration and Nicotine Flux Labels for E-cigarettes
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 2,500
- Enrollment target
NCT07553585: Clinical Trial NA study, sponsored by Yale University.
NCT07553585 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 2,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07553585, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 2,500 participants
- Enrollment target
Study Summary
Current labels for the nicotine in e-cigarette/vaping products do not sufficiently convey information to the public. The aims of this study include developing and validating two new types of labels for the nicotine in vaping products: nicotine concentration and nicotine flux (reflecting nicotine emissions). Investigators will survey youth (ages 14-20) and adults (ages 21+ \[21 is the legal age to purchase tobacco products in the U.S.\]) to evaluate the utility of several new labels investigators have developed.
Primary Outcome
To assess the impact of the new labels on understanding of the nicotine strength of e-cigarettes, perceived nicotine strength will be assessed. Participants will see each label at four nicotine strengths. After viewing each label/strength combination, participants will report on perceived strength. A correct response will be one that corresponds to what the label depicts. For instance, a response of "high nicotine" would be correct if a flux label visually depicts nicotine emissions in the high
Interventions
- OTHER Updated Labeling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
What is known before NCT07553585 opens enrollment
NCT07553585 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher).
The record links to 0 conditions, and to 1 intervention - of which Updated Labeling is the first listed.
NCT07553585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07553585 about?
NCT07553585 is a clinical study titled "Survey to Test the Nicotine Concentration and Nicotine Flux Labels for E-cigarettes". Current labels for the nicotine in e-cigarette/vaping products do not sufficiently convey information to the public. The aims of this study include developing and validating two new types of labels for the nicotine in vaping products: nicotine concentration and nicotine flux (reflecting nicotine emi...
What is the current status of trial NCT07553585?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2,500 participants. The study started on 2026-06-01. Estimated completion is 2026-12-15.
What interventions are being tested in trial NCT07553585?
The interventions under investigation include: Updated Labeling (OTHER).
Who is sponsoring clinical trial NCT07553585?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07553585's enrollment target sits among peer trials
2,500 44th of 2000 higher than 1,956 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI